More articles from Commentary
- Genetic discrimination arising from cancer risk assessments: A societal dilemma
The right to privacy of one’s most intimate biological secrets must be affirmed.
- The needs of science vs the needs of patients: Ethical concernsin cancer clinical trials
Patients in cancer trials are not data points; they are vulnerable people who often view a clinical trial as their last hope.
- Privacy protection for your patients: Understanding the federal requirements
On April 14, 2003, almost every medical provider in this country must implement new federal privacy rules. Here’s how.
- GUSTO V: Should it affect clinical practice?
The results of GUSTO V were equivocal and should not lead physicians to change how they treat myocardial infarction.
- The dangers of self-monitored dieting: What are our patients really doing?
Patient-monitored diets often leave questions of adherence and safety unanswered.
- C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
CRP elevations are a sensitive test for inflammation, hut are not specific.
- In cholesterol lowering, moderation kills
The author’s experience indicates that a low-fat, plant-based diet can lower cholesterol to less than 150 mg/dL and reverse coronary artery disease.
- Of rice, grain, and zeal: Lessons from Drs. Kempner and Esselstyn
Two physicians who successfully motivated their patients to make lifestyle changes were true believers.
- Fibrinolytic therapy in the elderly: Making sense of troubling new findings
Do patients older than 75 years with acute MI benefit from fibrinolytic therapy? For now, we have to live with uncertainty.